MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Telemedicine in a Himalayan country: unlocking the barrier in the management of Parkinson’s Disease

R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, G. Nepal, J. Yadav, P. Joshi (Kathmandu, Nepal)

Meeting: 2022 International Congress

Abstract Number: 381

Keywords: Parkinson’s

Category: Technology

Objective: To evaluate the feasibility of telemedicine among PD patients in Nepal.

Background: Nepal is a mountainous country occupying about 85% by Himalayas and hills region. About 80 % of its population are residing in rural areas with limited health services. Further, lack of health workers hinders in the management of Parkinson’s Disease (PD) patients.

Method: PD patients who sought follow up inquiry via hotline of department of Neurology at TUTH during travel restriction covid period, between April 2021 to August 2021 were enrolled. PD Patients who inquired to hotline of Neurology Department for follow up during the allocated period (April 2020 to April 2021), with access to Viber or messenger or WhatsApp.

Results: During the study, a total of 116 phone calls were received via Department of Neurology, TUTH hotline for a myriad of neurological conditions of which 64 were PD related. After, application of inclusion and exclusion criteria, a total of 52 patients was enrolled in our study. Our telemedicine initiative enrolled 52 patients, 40 of whom were male (76.9%). Participants’ mean age was 64.02±11.94 years and around 26 patients (50%) were from outside Kathmandu. About 30% patients were residing in rural areas. They had access to internet connection in the form of Wi-Fi in 82.6% and data only in 15.3%. During the pandemic, 20% patients experienced shortage of one or more PD medications. Of 52 patients, 38 patients (73%) were using telemedicine consultation for the first time and almost all for the first time for Parkinson disease. 78% patients responded that telemedicine consultation was at par with OPD consultation and all of them were satisfied with their first telemedicine encounter. The audio and video quality were mostly average or above, connection interruptions ≥2 times occurred only in 6 patients. The average consultation time was 24.82±6.921 minutes.

Conclusion: In countries with low resource settings, telemedicine could be used as a supportive tool in better management of PD patients. Telecommunication technology, internet and mobile services has been accessible to majority of general population despite geographical barriers. Pandemic has changed the way the medicine is practiced and embracing technology seems the way moving forward.

To cite this abstract in AMA style:

R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, G. Nepal, J. Yadav, P. Joshi. Telemedicine in a Himalayan country: unlocking the barrier in the management of Parkinson’s Disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/telemedicine-in-a-himalayan-country-unlocking-the-barrier-in-the-management-of-parkinsons-disease/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/telemedicine-in-a-himalayan-country-unlocking-the-barrier-in-the-management-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley